Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GC Medical Science corp.

Download Mobile App




Portable X-Ray Detector Leverages Dual-Energy at the Bedside

By HospiMedica International staff writers
Posted on 24 Sep 2020
A novel X-Ray flat panel detector (FPD) simultaneously provides bone and soft-tissue differentiation images in a single X-ray exposure. More...


The KA Imaging (Waterloo, Canada) Reveal detector is constructed with a unique triple stacked layer design, which permits spectral decomposition of the X-ray beam, allowing for high quantum efficiency of transmitted photons. The additional energy data enables the removal of motion artifacts and selective removal of the anatomical background, thus enhancing detectability of anatomies of interest and providing radiologists with unobstructed front and lateral views of both soft tissue and bone that are sharp and free of motion artifacts, increasing diagnostic sensitivity.

The retrofittable design is also capable of acquiring very high detective quantum efficiency (DQE) digital radiography images. When combined with dual energy capabilities, high quality images of the lungs and bones can be captured, which aids clinicians in visualization of masses with high sensitivity, fractures, pneumonia, and medical device such as catheters and PICC lines. Soft tissue and bone images are sharp and free of motion artifacts. Reveal is also portable, and can be taken to the bedside of patients, which is critical during these pandemic times.

“Reveal is the ideal retrofit solution as it will fit into any ISO standard size tray. Thanks to this feature, the cost of implementation can be reduced to a fraction of the price; whereas conventional dual exposure dual-energy systems can cost as high as half a million dollars, KA Imaging’s Reveal can be obtained at a quarter of this price,” said Amol Karnick, president and CEO of KA Imaging. “You can simply replace your old detector with Reveal, as it will work with any conventional portable or fixed x-ray source.”

“Recent experiences have shown that testing for viral RNA may not suffice as the only test to confirm or rule out the infection,” said Karim S. Karim, CTO of KA Imaging, on the Reveal’s application for COVID-19 detection. “This is where we can help, as radiological imaging, in some cases, has indicated presence of pulmonary disease even days earlier than PCR testing. Moreover, radiological imaging can follow the progress of COVID induced pneumonia over time, enabling timely decision making about treatment efficacy or need for ventilators.”

Related Links:
KA Imaging


Platinum Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Morcellator
TCM 3000 BL
External Defibrillator
HeartSave Y | YA
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Professor Bumsoo Han and postdoctoral researcher Sae Rome Choi of Illinois co-authored a study on using DNA origami to enhance imaging of dense pancreatic tissue (Photo courtesy of Fred Zwicky/University of Illinois Urbana-Champaign)

DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.